Friday, January 31, 2020

In-vitro Colorectal Cancer Screening Tests Market Will Generate New Growth Opportunities in Upcoming Year

The global in-vitro colorectal cancer screening tests market displays a consolidated vendor landscape. The top three players hold a key share in the market via long term contracts and merger. This restricts entry of new players in the global In-vitro colorectal cancer screening test market, notes Transparency Market Research. The high consolidation in the global in-vitro colorectal cancer screening test market is mainly due to the stringent rules and regulations of the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). The major players of the global In-vitro colorectal cancer screening tests market are Beckman Coulter, Sysmex Corporation, and Quest Diagnostics, Inc.
As per a recent report by Transparency Market Research (TMR) on the global in-vitro colorectal cancer screening tests market, analyst is estimated to reach a valuation of US$980.6 million by 2023 rising at an impressive CAGR of 7.5%. The global in-vitro colorectal cancer screening tests market was valued at US$602.3 million in 2016.
Geographically, North America holds a major portion of region share in the global in-vitro colorectal cancer screening tests market. This is mainly due to the increasing prevalence of cancer in the region. It has been expected to draw a king’s share of US$316.7 mn during the forecast period. On the basis of test type, fecal occult blood (FOB) testing has been the most commonly used diagnostic measure, owing to its long-term presence in the healthcare industry coupled with lower price.
Surging Cases of Cancer across Globe Support Demand
Increasing cases of cancer across the globe is a vital factor fueling global in-vitro colorectal cancer screening tests market in the near future. This is mainly because of a rise in the geriatric population, and changing lifestyle and food habits of people across the globe. In the recent times, non-invasive diagnostic tools are in high demand among patients owing to the convenience of their application.
Stringent Government Regulations for Tests and Tools Restricts New Entrants
Despite of growing demand of tests, the global in-vitro colorectal cancer screening tests market  is likely to suffer from a few restraints. Increased cost of treatment, lack of awareness, and strict regulation by the governing body over the use of in-vitro colorectal cancer screening tests are some of them. New players find it difficult to overcome barriers unlike established players.
The established players of the global in-vitro colorectal cancer screening tests market are investing enormous wealth for advance research and development activity. This is expected to drive the global in-vitro colorectal cancer screening tests market in the coming years.
More Trending Reports by Transparency Market Research:
Posted by at No comments:

Oncology Information System Market Set to Garner Staggering Revenues by 2022

The competition for global oncology information system market is getting fierce. Companies operating in the market are investing in the development of technologically advanced information systems. Besides this, rising partnerships and strategic collaborations is helping leading players to gain a strong foothold in the global oncology information system market. Some of the key players influencing the market are Elekta AB, Cerner Corporation, Accuray Incorporated, McKesson Corporation, and Koninklijke Philips N.V., among others.
The global market is likely to exhibit smooth growth in the coming years with 7.6% CAGR projected for the market over the 2017-2022 forecast period. According to TMR, the global oncology information system market was valued at US$2,285.6 mn in 2017 and is likely to rise to a valuation of US$3,293.8 mn by 2022. 
The software for patient information system segment was the largest revenue contributor in 2017 toward market growth. It is also anticipated to remain dominant in future.
North America is expected hold a largest share in the market due to technological advancement, well-established infrastructure, and higher penetration rate of systems in the healthcare practices. The global market in North America was valued at US$933.7 mn in 2017 and is expected to rise to a valuation of US$1,411.5 mn by 2022 at a robust 8.6% CAGR therein.
Prediction of Better Outcomes Growth Opportunities Worldwide
Oncology information systems have technological advancements such as conventional record maintenance. Along with surge in prevalence of cancer worldwide, drive the market. In addition, rise in awareness about the benefits of oncology information system is expected to supplement the market growth. The prediction of treatment outcomes and better management of patient profiles offered by oncology information systems is expected to attract patients with higher purchasing power and fuel innovations and subsequent market growth.
The advantages of oncology information systems such as planned treatment, future-proofing, and remote access are expected to increase the demand for these systems. This will also motivate the government organizations to upgrade their procedure from paper-based systems to paperless systems. Furthermore, an increase in disposable income among cancer patients, and a surge in prevalence of cancer cases are anticipated to fuel the market growth. The technological advancements in these systems, such as incorporation of patient portals will also boost the global market.
High-cost is Crucial for Widespread Adoption of Oncology Information System
High treatment costs associated with oncology information system and lack of healthcare IT professionals hamper the market growth. On the other hand, integration of oncology information systems for the treatment of rare cancer types and increased usage of artificial intelligence (AI) in oncology information systems are expected to present new opportunities to market players in the future.
The implementation of region-wide oncology information systems across different health practice locations has many challenges. A structure that supports project management and accountability contributes to success.
More Trending Reports by Transparency Market Research:
Posted by at No comments:

Oligonucleotide Synthesis Market Foreseen to Grow Exponentially by 2025

The global oligonucleotide synthesis market is likely to witness a stiff completion among the prominent players in the upcoming years. This is due to the continuous entry of new players in the market, states a report by the Transparency Market Research on the market. Some of the predominant players of the global oligonucleotide synthesis market are Applied Biosystems, Thermo Fisher Scientific, DNA Technologies, GE Healthcare and  BioAutomation,
A recently added report on global oligonucleotide synthesis market by Transparency Market Research estimates that the market is likely to attain worth of US$4.189 bn by 2025 growing at a steady CAGR of 11.2% from 2017 to 2025. Whereas the market stood at US$1.65 bn in 2016.
On the basis of geography, the global oligonucleotide synthesis market has been classified into five prime segments, namely, Asia-Pacific, North America, Latin America, the Middle East & Africa, and Europe. Among all these region North America continuous to dominate the market in the near future. This is due to the presence of better health care infrastructure and increasing usage of oligonucleotides by pharmaceutical companies of the region.  It accounts for 33.3 percent of total regional market share. Whereas on the basis of end user, research institutes segment holds maximum potential for the global oligonucleotide synthesis market.
Rising Applications of Synthesized Oligonucleotides in Research and Diagnostic to Rise Demand
The global oligonucleotides synthesis market has been on a sustained growth trajectory on account of the rapidly growing biotechnology and life sciences sectors. The increased usage of oligonucleotides in research and diagnostic fields propel growth of the global oligonucleotides synthesis market. On the basis of type, synthesis oligonucleotides segment is expected to register growth in the near future due high preference of pharmaceutical, biotechnology and research and diagnostic companies.
The ready to use and customization ability of the synthesis oligonucleotide is one factor which boost growth of the global oligonucleotide synthesis market. The increased demand in the segment has significantly increased the global oligonucleotides synthesis market.
Significant Rise in Pharmaceutical Industry buoy growth
 North America accounts for nearly one third of total market share of the global oligonucleotide synthesis market. Several factor which increased the consumption of oligonucleotide synthesis in the region are high prevalence of genetic diseases, increased research and development activity and presence of prominent players. Further, continuous emergence of new players in the region is making completion stiff, which is favorable for the growth of the global oligonucleotide synthesis market.
The market of global oligonucleotide synthesis market has heated up competition. Small players of the market are adopting new growth strategy like cutting down prices to draw customer attention. This has increased pressure on the other prominent players of the market to cut down the price. While prominent players are focusing towards the niche area of oligonucleotide to increase their market share.
This information is encompassed in the report by TMR, titled “Oligonucleotide Synthesis Market (Product - Reagents & Consumables, Equipment, and Synthesized Oligonucleotides (DNA Oligonucleotides and RNA Oligonucleotides); Application - Research (Polymerase Chain Reaction and Next Generation Sequencing), Therapeutics (Antisense Oligonucleotides, and Nucleic Acid Aptamers), and Diagnostics; End User - Biotechnology & Pharmaceutical Companies, Research Institutes, and Diagnostic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025.”
More Trending Reports by Transparency Market Research:
Posted by at No comments:

Fly Ash Market Set for Rapid Growth and Trend, by 2026

Transparency Market Research (TMR) witnesses the global fly ash market has a highly fragmented competitive scenario. Some of the companies operating in the global fly ash market are Boral Ltd., LafargeHolcim Ltd.., Cemex S.A.B. De C.V., Waste Management, Inc., Cement Australia Pty Limited, and Separation Technologies LLC. A growing number of new entrants in the global fly ash market are leading to an increasing level of competition in the next few years.
These vendors are trying to produce better-quality fly ash to be used as a prime component in cement manufacturing. These companies are trying to improve the quality of their products in order to stand alone in the market. Additionally, key players are trying to expand their business globally through numerous key strategies, which are expected to boost their growth over a few years.
According to TMR, the global styrenic polymers market in medical applications collected revenue of about US$5,237.1 mn in the year 2017 and is projected to collect revenue of US$9,080.9 mn by expanding with a CAGR of 7.1% over the forecast period from 2017 and 2025.
Based on the type, the Class F fly ash segment is dominating the global fly ash market owing to enlarging usage in the mass concrete and high strength mixtures. Based on region, Asia Pacific is dominating the global fly ash market and expected to remain dominant over the forecast period and account for the revenue of US$4,217.6 mn by the end of 2025.
Extensive Applications of Fly Ash to Propel Growth
Fly ash has extensive applications in the construction industry, being a key constituent of concrete structures. Immense usage of the material is mainly fuelling the growth of the global fly ash market. Fly ash is known for its sturdiness, long shelf life, high strength, and ability to mix. These properties are widening its applications and demand for fly ash, which is thrusting growth in the global fly ash market.
Ever-growing construction industry globally and mainly in the developing countries such as China and India is boosting demand for fly ash and likely to propel the growth of the global fly ash market. Additionally, the governments are trying to improve the infrastructure, which is again propelling the growth of the global fly ash market.  
Uneasy Availability of Raw Material to Hamper Growth
The production process of the fly ash is the environment polluter which is key factors restraining the growth of the global fly ash market. Additionally, the global fly ash market is witnessing steady growth due to lack of raw materials for manufacturing the material mainly in the underdeveloped or developing countries. Thus, obtaining ash is becoming difficult and hampering adoption of the fly ash. Furthermore, the high cost of raw materials is hampering the growth of the global fly ash market.
This information is encompassed in the report by TMR, titled “Fly Ash Market (Type - Class C and Class F; Application - Cement & Concrete, Structural Fills, Mining, Waste Stabilization, and Road Construction) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025.”
For the study, the fly ash market has been segmented as follows:
By Type
  • Class C
  • Class F
By Application
  • Cement & Concrete
  • Structural Fills
  • Mining Applications
  • Waste Stabilization
  • Road Construction
  • Others
Browse Chemical and Materials Market Research Reports
Popular Research Reports by TMR:
Posted by at No comments:

Clinical Laboratory Services Market: Lucrative Opportunities

According to TMR, the global clinical laboratory services market is expected to revenue of US$208.0 mn in the year 2016 to swell with a CAGR of 6% to attain revenue of US$361.3 bn over the forecast period between 2017 and 2025.
Based on the test type, the clinical chemistry test segment is likely to grow with more than 6% CAGR over the forecast period from 2017 to 2025 and expected to hold a dominant position over the forecast period. However, the medical biology and cytology segment is expected to expand with a lucrative CAGR of 6.5% by the 2025-end. Based on the service provider, the stand-alone laboratories segment is leading to account for more than 40% share over the forecast period. Based on the region, North America dominated the global clinical laboratory services market and is expected to remain dominant over the forecast period.
Growing Prevalence of Several Seasonal Diseases to Benefit Growth
Growing awareness toward diseases and benefits of early disease diagnosis coupled with high prevalence of seasonal diseases is propelling the growth of the global clinical laboratory services market. Additionally, the growing prevalence of various diseases due to poor lifestyle is creating a need for the advanced clinical laboratory services market. Furthermore, increasing incidence of infectious diseases is fuelling the need for the advanced clinical services for early detection of clinical laboratory services and one of the key factors fuelling the growth of the market.
Growing advancements in the technology are leading to boost adoption and heightened demand for these tests for its quick results, which is expected to provide a boost to the growth of the global clinical laboratory services market over the coming years. Furthermore, growing awareness about the benefits and availability of tests that offers advantages of early detection and medication is propelling the growth of the clinical laboratory services market.
Moreover, the growing geriatric population is likely to propel the demand for advanced healthcare and diagnosis systems are propelling the growth of the global clinical laboratory services market.  
Lack of Knowledge to Hamper Growth of Market
Despite these factors, lack of infrastructural advancements along with lack of exports to conduct these tests especially in the underdeveloped and developing countries is hampering the growth of the clinical laboratory services market. Additionally, stringent regulations imposed on the clinical laboratory services are restraining growth of the global clinical laboratory services market. Nonetheless, this picture is gradually changing and mainly in the developing countries where investment for healthcare is increasing. This investment is leading to open up doors for numerous opportunities for the players in the market. Additionally, taping the opportunities in the underdeveloped countries could offer lucrative opportunities for growth over the forecast period.   
Transparency Market Research (TMR) witnesses the global clinical laboratory services market has a highly fragmented competitive scenario. Some of the companies operating in the global clinical laboratory services market are SYNLAB International GmbH, Sonic Healthcare, Charles River Laboratories International Inc., Genomic Health Inc., Fresenius Medical Care, NeoGenomics Laboratories Inc., UNILABS, Quest Diagnostics Incorporated, and Laboratory Corporation of America Holdings. These players are increasingly adopting strategies such as merger & acquisitions and collaborations, which are leading to an increased level of consolidation in the global clinical laboratory services market.
This information is encompassed in the report by TMR, titled “Clinical Laboratory Services Market (Test Type - Clinical Chemistry, Medical Microbiology and Cytology, Food Intolerance Tests, Human and Tumor Genetics, and Other Esoteric Tests; Service Provider - Stand Alone Laboratories, Hospital based Laboratories, and Contract Research Organizations (CROs)) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025.”
More Trending Reports by Transparency Market Research:
  • Health Care Information Systems Market -
  • Laboratory Information System Market -
  • Laboratory Centrifuge Market -
Posted by at No comments:

Digital Pathology Market - Brief Analysis by Top Key Players

According to a recent report by Transparency Market Research, the global digital pathology market is likely to project a significant expansion with a robust CAGR of 12% within the forecast period from 2018 to 2026. The market in 2017 was valued around worth of US$ 340 Mn and is anticipated to reach over value of around US$ 900 Mn by the end of forecast period.
On the basis of application, the global digital pathology market is classified as consulting services, educational, diagnosis, and so on. Among these, in 2017, the diagnosis segment held the maximum share in the global market, as far as revenue is considered. Rise in prevalence of contagious ailments is one of the key factors supporting the demand in digital pathology market all over the world in coming years. Geographically, North America region led the market, trailed by Europe in 2017, based on revenue. In the forecast period, the region is likely to mark the CAGR of over 12%, owing to increased popularity of the digital pathology technology along with lack of skilled pathologists.
Increased Cases of Cancer to Fuel Demand Globally
Rise in number of cases of tumor and need for more precise pathological diagnosis, along with emergence of digitalization are the major factors propelling the growth in global digital pathology market across the globe. Shortage of skilled pathologists in the nations for example, the U.S. which leads to increased workload is another major factor fueling the demand in digital pathology market in coming years. Moreover, upgradation in diagnostic tests, increased number of preclinical and clinical trials, surged adoption of automation, and growth in medical infrastructure are important reasons behind the market growth. Nevertheless, high initial set up prices, sampling mistakes, and strict regulations are a few of the factors hampering the global growth of digital pathology market.
Rising Geriatric Population to Support Market growth of Digital Pathology
Rise in deployment of digital frameworks is anticipated to drive the global market in the forthcoming years. A couple of regions are foreseen to overwhelm the global digital pathology market in the following couple of years inferable from the increase in pervasiveness of tumor growth, advancement in innovation, and increase in old age population in the region. This is credited to the rise in occurrence of tumor, and increasing awareness in medical IT and its application in developed nations, for example, Australia and Japan. Developed nations such the U.K. and Germany display higher popularity about digital pathology and their applications. This is likely to help the market in the regions. The nations, for example, Japan, China, and India have an enormous potential for the development of market because of enhancing medicinal services foundation in the Asia Pacific.
The global digital pathology market are anticipated to witness a notable growth in the future years. The major players that are leading the in the global market are taking up various strategies for example, advancement in technology, mergers and acquisitions, collaborations, and tie-ups, so as to acquire the leading position in the market.  The key players leading in the global digital pathology market are OLYMPUS CORPORATION, Leica Biosystems Imaging, Inc, F. Hoffmann-La Roche Ltd, Mikroscan Technologies, Inc., GE Healthcare, Koninklijke Philips N.V., Inspirata, and Sectra AB.
The review is based on the findings of a report by Transparency Market Research, titled “Digital Pathology Market (Product Type - Image Analysis Software and Scanners; End use - Diagnostic Laboratories, Academic and Research Centers, Pharmaceutical Companies; Applications - Diagnosis, Consulting Services, Educational) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 – 2026.”
More Trending Reports by Transparency Market Research:
Posted by at No comments:

Thursday, January 30, 2020

Pyrogen Testing Market - Brief Analysis by Top Key Players

The global pyrogen testing market was valued at approximately US$ 680 Mn in 2017. It is projected to expand at a cumulative annual growth rate (CAGR) of 11% from 2018 to 2026, according to a new report published by Transparency Market Research (TMR) titled ‘Pyrogen Testing Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ The report suggests that rising demand for pyrogen testing in various pharmaceutical and biological products industries and rise in awareness about health care are expected to propel the pyrogen testing market in the near future. Additionally, increase in concerns about endotoxins present in drugs and their side-effects are anticipated to drive the global market.
North America and Europe are projected to dominate the global market. Highly structured health care industry and availability of well-defined FDA regulations for pharmaceutical and medical device product manufacturing, boost the pyrogen testing market in the region. The market in Asia Pacific is projected to expand at a prominent CAGR between 2018 and 2026. This is due to increased spending on public health care systems, significant rise in the development of pharmaceuticals & CROs, and increase in adoption of MAT test by pharmaceutical companies. The pyrogen testing market in Latin America is likely to expand at a moderate growth rate during the forecast period.
Planning To Lay Down Future Strategy? Request Brochure Of Pyrogen Testing Market
Increase in public and regulatory concerns about product safety to fuel market
Pyrogen testing was introduced in pharmaceutical products such as drugs and immunological products. Presently, it has been introduced in medical devices, implants, purification of water, and the food & beverage industry. The Food and Drug Administration (FDA) provides testing recommendations for biological products, drugs, and medical device firms. However, there are concerns about the testing recommendations and acceptance criteria through the United States Pharmacopeia (USP).
According to the European Medicines Agency (EMA) (April 2016), the Committee for Medicinal Products for Veterinary Use (CVMP) has developed a guidance report on quality, safety & efficacy, and environmental testing of medicinal, pharmaceutical, and immunological products. These factors are demanding more number of pyrogen tests of products for safety. According to the FDA, the Center for Devices and Radiological Health (CDRH) has adopted the USP Endotoxin Reference Standard and limits for medical device extracts, which are expressed in EU/ml (Endotoxin Units/ml). These improved and additional applications increased the demand for pyrogen testing products.
Adoption of limulus amoebocyte lysate (LAL) test is highest among end-user, which drives the market
Limulus amoebocyte lysate (LAL) is the most widely accepted and adopted test method for quality control of parenteral drugs, as it is an aqueous extract of blood cells from the horseshoe crab. LAL test is utilized for the detection of minute quantity of bacterial toxins or pyrogen in pharmaceuticals and medical devices. Increase in drug discovery and biological medical devices has driven the pyrogen testing market. The test is the first solution enabling adequate pyrogen testing of cell therapies, including blood transfusions, and medical devices. This fuels the adoption of limulus amoebocyte lysate (LAL) tests in several pharmaceutical and biotechnology industries.
To Obtain All-Inclusive Information On Forecast Analysis Of Pyrogen Testing Market , Request A Discount
Kits and reagents segments are estimated to expand at notable CAGR during the forecast period
Kits comprise pyrogen free test vials that already contain lyophilized LAL. These kits eliminate some of the tedious pipetting steps and are suitable for small labs with few samples. The kits segment is anticipated to expand at a relatively high growth rate, in terms of revenue, during the forecast period, owing to continuous innovations of new products by major as well as emerging players. The reagents used to preform pyrogen test are limulus amoebocyte lysate (LAL) reagent and endotoxin extracting solutions. Kits and reagents are also available in a single pack. Most reagents are required in large quantities and hence, are available in different packing. The reagents segment held a major share of the market due to regular usage of reagents for pyrogen testing. Reagents are also available in single packs, because most reagents are required in large quantities.
Pharmaceutical companies segment dominates the market and is estimated to prominent CAGR
In terms of end-user, the pharmaceutical companies segment accounted for a leading share of the global pyrogen testing market. The market share held by the segment is estimated to increase by the end of 2026. The pharmaceutical companies segment is anticipated to expand at a CAGR of more than 11% during the forecast period, due to growing importance of these companies not only in the field of conventional research, but also in the development and production of vital biomolecules and therapeutics. Discovery and launch of new products is fueling pharmaceutical companies and biotechnology companies segments. This, in turn, is projected to boost the global pyrogen testing market during the forecast period. These factors are expected to fuel the pharmaceutical companies segment at a significant pace between 2018 and 2026.
Asia Pacific offers considerable business development opportunity
North America and Europe accounted for a key share of the global pyrogen testing market in 2017. They are likely to gain market share by the end of 2026. Presence of well-established players in the region and increasing research and development activities by these players are key attributable factors for North America’s dominance of the global pyrogen testing market. Asia Pacific is projected to be a highly attractive market for pyrogen testing, and the region is likely to exhibit a high attractiveness index.
The market in Asia Pacific is projected to expand at a high CAGR of more than 13% during the forecast period, due to the rise of pyrogen testing in several pharmaceutical and biotechnology companies which are established in the countries in Asia Pacific country. This, in turn, is attributable to well-developed health care infrastructure, increase in health care expenditure, and rise in the number of local manufacturers providing innovative products at lower cost. The market in Latin America is expected to expand at a moderate pace during the forecast period.
Key trend of research and development among leading players to increase in geographic presence
The report also provides profiles of leading players operating in global pyrogen testing market. Thermo Fisher Scientific, Inc., Merck KGaA, Charles River Laboratories International, Inc., GenScript, Lonza Group, Sanquin, and WuXi AppTec are leading players operating in the global pyrogen testing market. They account for a significant share of the global market. Companies operating in the pyrogen testing industry are focused on increasing their geographic presence by means of strategic acquisitions and collaborations with leading players in their respective domains and geographies. In 2017, the Merck KGaA formed a strategic alliance with Baylor College of Medicine, Houston, Texas and a vaccine product development partnership with Texas Children’s Hospital Center for vaccine development in the U.S. in order to advance vaccine research and development for neglected and emerging infections.
In 2017, the Merck KGaA extended its partnership with Samsung BioLogics to accelerate the process of development and clinical material production at small biotech startups, focusing on novel drug development, for which Samsung BioLogics acts as a contract manufacturer. Other prominent players operating in the global pyrogen testing include Hyglos GmbH – a bioMérieux Company, Wako Chemicals USA, Inc., and Associates of Cape Cod, Inc.
Posted by at No comments:

Caspofungin Market to Observe Strong Development by 2027

Transparency Market Research (TMR) has published a new report titled, ‘Caspofungin Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027.’ According to the report, the global caspofungin market was valued at US$ 484.20 Mn in 2018 and is projected to expand at a CAGR of 0.18% from 2019 to 2027. Rise in prevalence of chronic diseases such as cancer and diabetes, increase in the geriatric population, and surge in awareness about advanced therapies are factors anticipated to propel the global caspofungin market from 2019 to 2027.
The global population is aging rapidly. According to the WHO, nearly 2 billion people are expected to be aged 60 and above by 2050, accounting for 16.7% of the global population. The population in developed countries such as those in Western Europe, Japan, and the U.S. is aging at a rapid pace. Invasive fungal infections have become an increasing problem in older adults.
Opportunistic fungal infections have increased in older patients because they are more likely to receive transplanted solid organs or bone marrow, undergo aggressive treatment of malignancies, and take immunosuppressive medications for dermatologic and rheumatologic diseases. Compared to young patients, older patients are less able to handle invasive endemic or opportunistic infections, and outcomes of infection are frequently worse for elder patients. Increase in the geriatric population is expected to be a major factor likely to augment the global market during the forecast period.
Planning To Lay Down Future Strategy? Request Brochure Of Caspofungin Market
The report offers detailed segmentation of the global caspofungin market based on indication, distribution channel, and region. In terms of indication, the candidiasis segment is anticipated to account for large market share due to increase in applications of echinocandins in candidiasis and benefits of echinocandins over other antifungals. The benefits of echinocandins include low risk of drug-drug interactions, novel mechanism of action, and lesser adverse effects. Echinocandins demonstrate compelling activity against Candida species and are the preferred first-line therapy for patients with invasive candidiasis. It has been reported that more than 60% of candidemia patients receive echinocandin during therapy.
Hospital Pharmacies Segment to Account for Major Share
The hospital pharmacies segment is projected to account for leading share of the global market by 2027. Rise in prevalence of mycosis in the elderly population has increased the number of hospital visits. This in turn is likely to boost the growth of the segment.
To Obtain All-Inclusive Information On Forecast Analysis Of Caspofungin Market , Request A Discount
North America Market to Expand at Rapid Pace
North America held major share of the global market in terms of revenue in 2018 and is projected to sustain its position during the forecast period. High awareness about latest health care technologies and higher purchasing power are attributed to the larger market share of the region. Favorable reimbursement policies in the region also enable patients to avail the best health care facilities. Europe is anticipated to be the second largest market in terms of share and revenue during the forecast period. Developed health care infrastructure in the region has helped patients undergoing therapies in covering their expenditure. Most health care providers in countries such as Germany, the U.K., and France provide full or partial coverage of costs related to treatment, medication, physicians cost, and tests depending on the patient’s insurance plan and income.
Merck & Co., Inc., Mylan N.V., and Fresenius SE & Co. KGaA to Lead Global Market
The report also provides profiles of leading players operating in the global caspofungin market. These include Teva Pharmaceutical Industries Ltd., Gland Pharma Limited, and Xellia Pharmaceuticals.
Posted by at No comments:

Allergy Immunotherapy Market Estimated to Expand at a Robust CAGR by 2025

The global market for allergy immunotherapy was initially valued at US$1.37 bn back in the year 2016. According to the research report published by Transparency Market Research, the global allergy immunotherapy market will exhibit an impressive CAGR of 10.7% for the projection period of 2017 to 2025. With this massive growth rate, market is expected to cross the valuation US$3.33 billion by the end of 2025. According to the research report, the growing prevalence of allergy diseases across the world and increasing awareness about the new treatment methods of allergies are some of the key reasons behind the growth of the global allergy immunotherapy market.
Planning To Lay Down Future Strategy? Request Brochure Of Allergy Immunotherapy Market
Increased Funding for R&D Activities to Fuel Market Growth
There are some other important factors that are also helping to push the development of the global allergy immunotherapy market. One of the key driving factor for the market growth has been the recent rise in investments and funding to fuel clinical researches and other activities of research and development. In addition to this, recent launch of new therapies is also expected to help the development and wider spread of global allergy immunotherapy market.
Europe to Emerge as Leading Regional Market Segment
In terms of regional segment, there are five key regions that divide the global allergy immunotherapy market. These regions are North America, Asia Pacific, Middle East and Africa, Latin America, and Europe. Among these, the regional markets of Europe and North America are expected to contribute significantly for the overall development of the global allergy immunotherapy market. This development of these regional segment can be primarily attributed to the increasing user or patient base in the region that are suffering from different kinds of allergies, huge budgets for clinical research and development activities, introduction of new and innovative therapies, and growing awareness about treatment of allergy disorders.
In addition to this, governmental and non-governmental awareness campaigns raised in the countries of these regions is also expected to push the development of the allergy immunotherapy market in Europe and North America. Europe in particular, is expected to exhibit a CAGR of over 11.5% during this given forecast period of 2017 to 2025. Such factors are thus helping to drive the overall growth of the global allergy immunotherapy market.
To Obtain All-Inclusive Information On Forecast Analysis Of Allergy Immunotherapy Market , Request A Discount
The competitive landscape of the global allergy immunotherapy market is a highly intense and fragmented. The fragmentation of the global market’s competitive landscape is due to the presence of several notable key players operating in the space. These leading companies in the global market are expected to focus on mergers, takeover, and strategic partnerships so as to keep ahead of the growing competition in the market. In addition to this, these companies are also expected to invest heavily in developing new products to cater to the unmet demands of the end-users. Some of the leading companies in the global allergy immunotherapy market include names such as HAL Allergy Group, Merck KGaA, Allergopharma, Allergy Therapeutics, ALK-Abello AS, and Stallergenes Greer among others.
Posted by at No comments:

Anti-Venom Market is Expected to Expand at an Impressive Rate by 2025

The global anti-venom market is prophesied in a report by Transparency Market Research (TMR) finds highly competitive owing to presence of strong players in the market. The Anti-Venom Market is fragmented, with presence of several large industry players. Some of the key players in the global anti-venom market including CSL Behring, Haffkine Bio-Pharmaceutical Corporation Ltd, Bharat Serums and Vaccines Ltd., Vacsera, Rare Therapeutics, and Vins Bioproducts Limited.
The global anti-venom market report by TMR expects to be valued at a US$2.9 bn by the end of 2025 registering a CAGR of 6.8% during the forecast period from 2017 to 2025. In 2016, the market was valued at US$1.6 bn. In terms of anti-venom type, polyvalent is dominated with largest share in 2016. In 2017, the Middle East and Africa (MEA) dominated the market with revenue of around US$0.7 bn.
Planning To Lay Down Future Strategy? Request Brochure Of Anti-Venom Market
Increasing Prevalence of Venomous Bites to Boost Demand for Anti-Venom Treatment
Biotechnology and healthcare industry is witnessing a significant demand from developing economies globally. The key factor driving the growth of anti-venom market is the demand for anti-venom treatment being the only authorized treatment for snake bite with no option for alternative treatment. Violation of forest lands for agricultural and housing purposes has enabled human to be in close in poisonous insects and animals, thus increasing prevalence of venomous bites. High prevalence of scorpion bites, snake bites, and other animal or insect bites such as fish stings are other factors supporting growth of anti-venom market.
Continuous research and development (R&D) to provide advanced drugs and standard treatment for poisonous insect bite has boosted the development of the anti-venom market. Rising demand for anti-venoms in developing countries has encouraged key players to be present in the countries including India and Africa to offer anti-venom products at affordable price. This is another factor supporting growth of the global anti-venoms market over forecast period.
To Obtain All-Inclusive Information On Forecast Analysis Of Anti-Venom Market , Request A Discount
Increased in Individual Per Capita Incomes to Offer Lucrative Opportunity for Growth
However, high cost of anti-venom owing to high production cost in some regions and lack in availability of essential anti-venom stock is hampering growth of anti-venom market. Nevertheless, the developing economic conditions globally is creating a huge opportunity for the expansion of the anti-venom market. This has increased in individual per capita incomes is bound to increase spending capacity on health care. Especially in the developing countries of Asia Pacific and Middle East, growing population coupled with per capita income are important factor that are boosting growth of the market.
Posted by at No comments:
Subscribe to: Posts (Atom)